Literature DB >> 5001942

Opsonic defect in patients with cystic fibrosis of the pancreas.

W D Biggar, B Holmes, R A Good.   

Abstract

Cystic fibrosis of the pancreas is one of the most common inborn errors of metabolism. The high incidence of morbidity and mortality in these patients is primarily due to severe and frequent pulmonary infection. To date, no immune deficiency has been found in cystic fibrosis patients. Their sera contain normal quantities of immunoglobulins and hemolytic complement. In an assay of phagocytosis by alveolar macrophage, six out of nine sera from cystic fibrosis patients failed to support normal phagocytosis of Pseudomonas aeruginosa. This deficiency could be corrected by increasing the concentration of serum used in the assay. By contrast, their sera supported normal phagocytosis of Pseudomonas by blood polymorphonuclear leukocytes and continued to support normal phagocytosis when serum dilutions were used. Two patients with severe isolated deficiences of serum immunoglobulin A were found to have a similar defect in the alveolar macrophage assay, but normal phagocytosis by polymorphonuclear leukocytes. It is postulated that cystic fibrosis patients may have a quantitative and (or) functional defect of IgA antibodies, specific for Pseudomonas, and possibly of importance in the pathogenesis of their pulmonary disease.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5001942      PMCID: PMC389278          DOI: 10.1073/pnas.68.8.1716

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  C'-1 fixation by human isoagglutinins: fixation of C'-1 by gamma-G and gamma-M but not by gamma-A antibody.

Authors:  T Ishizaka; K Ishizaka; T Borsos; H Rapp
Journal:  J Immunol       Date:  1966-11       Impact factor: 5.422

2.  The IgA system. 3. IgA levels in the serum and saliva of pediatric patients--evidence for a local immunological system.

Authors:  M A South; W J Warwick; F A Wolheim; R A Good
Journal:  J Pediatr       Date:  1967-11       Impact factor: 4.406

3.  Deficiency of pneumococcal serum opsonizing activity in sickle-cell disease.

Authors:  J A Winkelstein; R H Drachman
Journal:  N Engl J Med       Date:  1968-08-29       Impact factor: 91.245

4.  Immunoglobulin production in bronchial mucosa and bronchial lymph nodes, particularly in cystic fibrosis of the pancreas.

Authors:  F J Martinez-Tello; D G Braun; W A Blanc
Journal:  J Immunol       Date:  1968-11       Impact factor: 5.422

5.  Bacterial precipitins in serum of patients with cystic fibrosis.

Authors:  M W Burns; J R May
Journal:  Lancet       Date:  1968-02-10       Impact factor: 79.321

6.  Impaired leucotactic responsiveness in a child with recurrent infections.

Authors:  P A Ward; R J Schlegel
Journal:  Lancet       Date:  1969-08-16       Impact factor: 79.321

7.  A familial deficiency of the phagocytosis-enhancing activity of serum related to a dysfunction of the fifth component of complement (C5).

Authors:  M E Miller; U R Nilsson
Journal:  N Engl J Med       Date:  1970-02-12       Impact factor: 91.245

8.  Abnormal serum factor in patients with cystic fibrosis of the pancreas.

Authors:  A Spock; H M Heick; H Cress; W S Logan
Journal:  Pediatr Res       Date:  1967-05       Impact factor: 3.756

9.  Serum immunoglobulin levels in cystic fibrosis.

Authors:  R H Schwartz
Journal:  Am J Dis Child       Date:  1966-04

10.  Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection.

Authors:  R I Lehrer; M J Cline
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

View more
  20 in total

1.  Bactericidal mechanisms in rabbit alveolar macrophages: evidence against peroxidase and hydrogen peroxide bactericidal mechanisms.

Authors:  W D Biggar; S Buron; B Holmes
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

Review 2.  Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good?

Authors:  M Berger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

3.  Quantitation of the third component of human complement attached to the surface of opsonized bacteria: opsonin-deficient sera and phagocytosis-resistant strains.

Authors:  H A Verbrugh; W C van Dijk; M E van Erne; R Peters; P K Peterson; J Verhoef
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

Review 4.  Cystic fibrosis: current concepts.

Authors:  M J Polley; A G Bearn
Journal:  J Med Genet       Date:  1974-09       Impact factor: 6.318

Review 5.  Immunological abnormalities in cystic fibrosis: chicken or egg?

Authors:  M E Hodson
Journal:  Thorax       Date:  1980-11       Impact factor: 9.139

6.  Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.

Authors:  R B Fick; G P Naegel; S U Squier; R E Wood; J B Gee; H Y Reynolds
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

7.  Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.

Authors:  I Eichler; L Joris; Y P Hsu; J Van Wye; R Bram; R Moss
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

8.  Interactions of Pseudomonas aeruginosa with immunoglobulins and complement in sputum.

Authors:  S Hann; D S Holsclaw
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

Review 9.  Cystic fibrosis. Infection and immunity to Pseudomonas.

Authors:  R U Sorensen; R L Waller; J D Klinger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

10.  Functional characterization of macrophage receptors for in vitro phagocytosis of unopsonized Pseudomonas aeruginosa.

Authors:  D P Speert; S D Wright; S C Silverstein; B Mah
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.